PainChek expands into infant market, with ambitions to scale globally
Read the full article on PainChek® featured in Stockhead, - PainChek has just released its infant app and is set to expand globally 24 May 2021.
Independent evaluation of PainChek in Australian aged care facilities reports positive clinical outcomes
In 2019, the Australian Department of Health provided a $5M grant to support the national roll-out of PainChek®.
Budget boost for aged care pain management
Older Australians unable to communicate their pain, including people living with dementia and disability, will benefit from the Morrison Government’s 2021 budget.
PainChek® is expanding its presence in the UK as COVID-19 restrictions ease
A year after the first COVID-19 lockdown, the social care sector is reopening its doors — reuniting residential care home residents with their loved ones.
PainChek Universal: enabling best practice pain assessment for all people, everywhere
In 2016, we at PainChek began our journey with a mission to support those who are unable to reliably self-report. Over the past half-decade, PainChek technology has benefited thousands of people…
Press Release – Social care organisations unite to demand government support for dementia care tech
A cohort of 18 leading organisations from across the UK’s health and social care sectors, including National Care Forum, Care England, National Care Association and PainChek have called on PM Boris…
Paper vs. digital pain assessment tools
According to the World Health Organisation (WHO), access to effective pain management is classified as a human right. However, for many aged care providers, demonstrating that this is the case in…
Quarterly news update: PainChek® delivers sales growth during aged care lockdown, announces PainChek® Universal Pain Assessment Solution and accelerates market expansion
The end of 2020 was challenging for Australians, but we are pleased to share that PainChek® finished the year off strong. In the December quarter, we continued to bring our digital pain assessment…
PainChek CEO joined Reach Markets for their fortnightly webcast ‘The Insider’
Fears grow for dementia patients following COVID-19 lockdowns. With a coronavirus outbreak in Sydney leading to a North Shore lockdown, new research suggests COVID-induced isolation is taking a…
PainChek and Nulsen Group commence Australian-first trial in disability care
This year on International Day of Persons with Disabilities, PainChek and Nulsen Group have officially commenced a 6-month trial of the PainChek® digital pain assessment tool on people with…
PainChek receives regulatory clearance from Health Canada
PainChek is pleased to announce it has received regulatory clearance from Health Canada, allowing it to move into the $5 billion in-home health and support services market in the country..
Painchek (ASX: PCK) Quarterly Report Webinar and Q&A
PainChek has continued to deliver growth in the Australian aged care sector, while also exploring opportunities in the home care, hospital, and disability segments, and progressing global expansion…
